Notably, the method of delivering exogenous VEGF-C has been exemplified well through the research of Song et al., in which delivery of VEGF-C led to increased immune cell recruitment and a more potent immune response in brain tumor mice models (Song et al., 2020). Here, VEGFC is linked to brain neoplasm.